Company Valuation: Metro Healthcare

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 218.5 333 419.4 388.5 180.9 215.4
Change - 52.45% 25.93% -7.35% -53.44% 19.05%
Enterprise Value (EV) 1 220.2 328.1 414.5 390.4 140.9 174.8
Change - 49.04% 26.33% -5.81% -63.9% 24.05%
P/E 39.8x 35.3x 83.6x 62.2x 47.2x 36.7x
PBR 9.63x 9.7x 11.9x 10.4x 2.85x 2.87x
PEG - 0.5x -1.8x 2.5x -1.2x 1.3x
Capitalization / Revenue 7.71x 7.88x 10.4x 8.69x 3.72x 4.27x
EV / Revenue 7.77x 7.76x 10.3x 8.74x 2.9x 3.47x
EV / EBITDA 30.5x 23.5x 41.6x 33.5x 13.3x 16.9x
EV / EBIT 38.5x 27.4x 56.8x 44x 19x 25.2x
EV / FCF 131x 40.6x 63.3x 66.8x 30.3x 28.1x
FCF Yield 0.76% 2.46% 1.58% 1.5% 3.3% 3.56%
Dividend per Share 2 0.0015 0.0016 0.005 0.0053 0.0054 0.0065
Rate of return 0.56% 0.4% 0.98% 1.12% 2.45% 2.95%
EPS 2 0.006781 0.0115 0.006099 0.007597 0.004657 0.005987
Distribution rate 22.1% 13.9% 82% 69.8% 116% 109%
Net sales 1 28.33 42.26 40.27 44.69 48.65 50.42
EBITDA 1 7.215 13.99 9.972 11.66 10.62 10.37
EBIT 1 5.718 11.98 7.296 8.869 7.403 6.94
Net income 1 5.477 9.438 5.016 6.248 4.559 5.862
Net Debt 1 1.714 -4.9 -4.847 1.903 -39.97 -40.53
Reference price 2 0.2700 0.4050 0.5100 0.4725 0.2200 0.2200
Nbr of stocks (in thousands) 809,080 822,280 822,280 822,280 822,280 978,905
Announcement Date 4/30/21 4/29/22 4/28/23 2/29/24 4/30/25 4/30/26
1MYR in Million2MYR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 51.06M
32.15x2.98x13.39x1.37% 18.11B
51.54x4.43x28.85x0.27% 13.45B
18.87x2.25x10.49x0.66% 11.86B
25.68x2.97x10.3x1.56% 11.32B
85.95x7.92x32.6x - 10.55B
24.4x1.98x15.98x0.16% 9.96B
19.47x2.81x11.65x4.18% 9.39B
39.14x1.02x8.49x1.66% 8.46B
13.2x1.33x8.01x2.1% 8.05B
Average 34.49x 3.08x 15.53x 1.49% 10.12B
Weighted average by Cap. 35.19x 3.19x 16.02x 1.39%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. 0329 Stock
  4. Valuation Metro Healthcare